Health freedom has just been handed a significant victory by the United States District Court for the District of Columbia, which ruled last week that the U.S. Food and Drug Administration (FDA) violated the First Amendment rights of a nutritional supplement company when it censored truthful, scientifically-backed claims about how selenium can help reduce the risk of cancer.
See the ANH announcement at: http://www.anh-usa.org/court-finds-…
Essentially, the FDA applied its doctrine of censorship to these selenium supplements in the same way it oppresses truthful and scientifically-supported health claims across all dietary supplements. The purpose of the FDA’s censorship of truthful information about the health benefits of dietary supplements, as NaturalNews readers already know, is to keep the American people nutritionally illiterate and protect the profits of the pharmaceutical industry.
In this court case, ALLIANCE FOR NATURAL HEALTH, et al. vs.
KATHLEEN SEBELIUS, et al., the judge ruled that the FDA violated the First Amendment rights of the plaintiffs by restricting their free speech about the anti-cancer benefits of their selenium supplements.
As explained by health freedom attorney Jonathan Emord who argued the case before the Court:
“The decision… reaffirms that FDA is subject to the strictures of the First Amendment in its evaluation of health claims and it faults FDA for failing to follow that standard, holding its suppression of the selenium-cancer risk reduction claims unconstitutional.”
Emord goes onto explain:
“The Court concludes that the FDA… has not provided any empirical evidence, such as ‘studies’ or ‘anecdotal evidence,’ that consumers would be misled by… plaintiffs’ claims were they accompanied by qualifications. Moreover, the explanation the FDA offers to demonstrate that plaintiffs’ claims are misleading